Global Parkinson Disease Drug Market Research Report 2023(Status and Outlook)

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,800	146 Pages	Bosson Research	May, 2023	BOSS18175910

Best Price Guarantee
Price	from $2,800
Length	146 Pages
Publisher	Bosson Research
Published Date	May, 2023
SKU	BOSS18175910

Global Parkinson Disease Drug Market Research Report 2023(Status and Outlook)

Report Overview

Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement.

The Global Parkinson Disease Drug Market Size was estimated at USD 5492.00 million in 2022 and is projected to reach USD 8367.62 million by 2029, exhibiting a CAGR of 6.20% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Parkinson Disease Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Parkinson Disease Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Parkinson Disease Drug market in any manner.

Global Parkinson Disease Drug Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Merck

Akorn

GSK

Novartis

Boehringer Ingelheim

Teva Pharmaceutical

Abbvie

Kyowa Hakko Kirin Pharma

Astellas Pharma

Desitin Arzneimittel

Endo Pharmaceuticals

F.Hoffmann-La Roche

H.Lundbeck

Valeant

Apokyn

Orion

Stada Arzneimittel

US WorldMeds

Bausch Health

Market Segmentation (by Type)

Sinemet-CR

Trastal

Madopar

COMT Inhibitor

Other

Market Segmentation (by Application)

Mining Industry

Chemical Industry

Electroplating

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Parkinson Disease Drug Market

Overview of the regional outlook of the Parkinson Disease Drug Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

1 Research Methodology and Statistical Scope: 1.1 Market Definition and Statistical Scope of Parkinson Disease Drug; 1.2 Key Market Segments; 1.2.1 Parkinson Disease Drug Segment by Type; 1.2.2 Parkinson Disease Drug Segment by Application; 1.3 Methodology & Sources of Information; 1.3.1 Research Methodology; 1.3.2 Research Process; 1.3.3 Market Breakdown and Data Triangulation; 1.3.4 Base Year; 1.3.5 Report Assumptions & Caveats
2 Parkinson Disease Drug Market Overview: 2.1 Global Market Overview; 2.1.1 Global Parkinson Disease Drug Market Size (M USD) Estimates and Forecasts (2018-2029); 2.1.2 Global Parkinson Disease Drug Sales Estimates and Forecasts (2018-2029); 2.2 Market Segment Executive Summary; 2.3 Global Market Size by Region
3 Parkinson Disease Drug Market Competitive Landscape: 3.1 Global Parkinson Disease Drug Sales by Manufacturers (2018-2023); 3.2 Global Parkinson Disease Drug Revenue Market Share by Manufacturers (2018-2023); 3.3 Parkinson Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3); 3.4 Global Parkinson Disease Drug Average Price by Manufacturers (2018-2023); 3.5 Manufacturers Parkinson Disease Drug Sales Sites, Area Served, Product Type; 3.6 Parkinson Disease Drug Market Competitive Situation and Trends; 3.6.1 Parkinson Disease Drug Market Concentration Rate; 3.6.2 Global 5 and 10 Largest Parkinson Disease Drug Players Market Share by Revenue; 3.6.3 Mergers & Acquisitions, Expansion
4 Parkinson Disease Drug Industry Chain Analysis: 4.1 Parkinson Disease Drug Industry Chain Analysis; 4.2 Market Overview of Key Raw Materials; 4.3 Midstream Market Analysis; 4.4 Downstream Customer Analysis
5 The Development and Dynamics of Parkinson Disease Drug Market: 5.1 Key Development Trends; 5.2 Driving Factors; 5.3 Market Challenges; 5.4 Market Restraints; 5.5 Industry News; 5.5.1 New Product Developments; 5.5.2 Mergers & Acquisitions; 5.5.3 Expansions; 5.5.4 Collaboration/Supply Contracts; 5.6 Industry Policies
6 Parkinson Disease Drug Market Segmentation by Type: 6.1 Evaluation Matrix of Segment Market Development Potential (Type); 6.2 Global Parkinson Disease Drug Sales Market Share by Type (2018-2023); 6.3 Global Parkinson Disease Drug Market Size Market Share by Type (2018-2023); 6.4 Global Parkinson Disease Drug Price by Type (2018-2023)
7 Parkinson Disease Drug Market Segmentation by Application: 7.1 Evaluation Matrix of Segment Market Development Potential (Application); 7.2 Global Parkinson Disease Drug Market Sales by Application (2018-2023); 7.3 Global Parkinson Disease Drug Market Size (M USD) by Application (2018-2023); 7.4 Global Parkinson Disease Drug Sales Growth Rate by Application (2018-2023)
8 Parkinson Disease Drug Market Segmentation by Region: 8.1 Global Parkinson Disease Drug Sales by Region; 8.1.1 Global Parkinson Disease Drug Sales by Region; 8.1.2 Global Parkinson Disease Drug Sales Market Share by Region; 8.2 North America; 8.2.1 North America Parkinson Disease Drug Sales by Country; 8.2.2 U.S.; 8.2.3 Canada; 8.2.4 Mexico; 8.3 Europe; 8.3.1 Europe Parkinson Disease Drug Sales by Country; 8.3.2 Germany; 8.3.3 France; 8.3.4 U.K.; 8.3.5 Italy; 8.3.6 Russia; 8.4 Asia Pacific; 8.4.1 Asia Pacific Parkinson Disease Drug Sales by Region; 8.4.2 China; 8.4.3 Japan; 8.4.4 South Korea; 8.4.5 India; 8.4.6 Southeast Asia; 8.5 South America; 8.5.1 South America Parkinson Disease Drug Sales by Country; 8.5.2 Brazil; 8.5.3 Argentina; 8.5.4 Columbia; 8.6 Middle East and Africa; 8.6.1 Middle East and Africa Parkinson Disease Drug Sales by Region; 8.6.2 Saudi Arabia; 8.6.3 UAE; 8.6.4 Egypt; 8.6.5 Nigeria; 8.6.6 South Africa
9 Key Companies Profile: 9.1 Merck; 9.1.1 Merck Parkinson Disease Drug Basic Information; 9.1.2 Merck Parkinson Disease Drug Product Overview; 9.1.3 Merck Parkinson Disease Drug Product Market Performance; 9.1.4 Merck Business Overview; 9.1.5 Merck Parkinson Disease Drug SWOT Analysis; 9.1.6 Merck Recent Developments; 9.2 Akorn; 9.2.1 Akorn Parkinson Disease Drug Basic Information; 9.2.2 Akorn Parkinson Disease Drug Product Overview; 9.2.3 Akorn Parkinson Disease Drug Product Market Performance; 9.2.4 Akorn Business Overview; 9.2.5 Akorn Parkinson Disease Drug SWOT Analysis; 9.2.6 Akorn Recent Developments; 9.3 GSK; 9.3.1 GSK Parkinson Disease Drug Basic Information; 9.3.2 GSK Parkinson Disease Drug Product Overview; 9.3.3 GSK Parkinson Disease Drug Product Market Performance; 9.3.4 GSK Business Overview; 9.3.5 GSK Parkinson Disease Drug SWOT Analysis; 9.3.6 GSK Recent Developments; 9.4 Novartis; 9.4.1 Novartis Parkinson Disease Drug Basic Information; 9.4.2 Novartis Parkinson Disease Drug Product Overview; 9.4.3 Novartis Parkinson Disease Drug Product Market Performance; 9.4.4 Novartis Business Overview; 9.4.5 Novartis Parkinson Disease Drug SWOT Analysis; 9.4.6 Novartis Recent Developments; 9.5 Boehringer Ingelheim; 9.5.1 Boehringer Ingelheim Parkinson Disease Drug Basic Information; 9.5.2 Boehringer Ingelheim Parkinson Disease Drug Product Overview; 9.5.3 Boehringer Ingelheim Parkinson Disease Drug Product Market Performance; 9.5.4 Boehringer Ingelheim Business Overview; 9.5.5 Boehringer Ingelheim Parkinson Disease Drug SWOT Analysis; 9.5.6 Boehringer Ingelheim Recent Developments; 9.6 Teva Pharmaceutical; 9.6.1 Teva Pharmaceutical Parkinson Disease Drug Basic Information; 9.6.2 Teva Pharmaceutical Parkinson Disease Drug Product Overview; 9.6.3 Teva Pharmaceutical Parkinson Disease Drug Product Market Performance; 9.6.4 Teva Pharmaceutical Business Overview; 9.6.5 Teva Pharmaceutical Recent Developments; 9.7 Abbvie; 9.7.1 Abbvie Parkinson Disease Drug Basic Information; 9.7.2 Abbvie Parkinson Disease Drug Product Overview; 9.7.3 Abbvie Parkinson Disease Drug Product Market Performance; 9.7.4 Abbvie Business Overview; 9.7.5 Abbvie Recent Developments; 9.8 Kyowa Hakko Kirin Pharma; 9.8.1 Kyowa Hakko Kirin Pharma Parkinson Disease Drug Basic Information; 9.8.2 Kyowa Hakko Kirin Pharma Parkinson Disease Drug Product Overview; 9.8.3 Kyowa Hakko Kirin Pharma Parkinson Disease Drug Product Market Performance; 9.8.4 Kyowa Hakko Kirin Pharma Business Overview; 9.8.5 Kyowa Hakko Kirin Pharma Recent Developments; 9.9 Astellas Pharma; 9.9.1 Astellas Pharma Parkinson Disease Drug Basic Information; 9.9.2 Astellas Pharma Parkinson Disease Drug Product Overview; 9.9.3 Astellas Pharma Parkinson Disease Drug Product Market Performance; 9.9.4 Astellas Pharma Business Overview; 9.9.5 Astellas Pharma Recent Developments; 9.10 Desitin Arzneimittel; 9.10.1 Desitin Arzneimittel Parkinson Disease Drug Basic Information; 9.10.2 Desitin Arzneimittel Parkinson Disease Drug Product Overview; 9.10.3 Desitin Arzneimittel Parkinson Disease Drug Product Market Performance; 9.10.4 Desitin Arzneimittel Business Overview; 9.10.5 Desitin Arzneimittel Recent Developments; 9.11 Endo Pharmaceuticals; 9.11.1 Endo Pharmaceuticals Parkinson Disease Drug Basic Information; 9.11.2 Endo Pharmaceuticals Parkinson Disease Drug Product Overview; 9.11.3 Endo Pharmaceuticals Parkinson Disease Drug Product Market Performance; 9.11.4 Endo Pharmaceuticals Business Overview; 9.11.5 Endo Pharmaceuticals Recent Developments; 9.12 F.Hoffmann-La Roche; 9.12.1 F.Hoffmann-La Roche Parkinson Disease Drug Basic Information; 9.12.2 F.Hoffmann-La Roche Parkinson Disease Drug Product Overview; 9.12.3 F.Hoffmann-La Roche Parkinson Disease Drug Product Market Performance; 9.12.4 F.Hoffmann-La Roche Business Overview; 9.12.5 F.Hoffmann-La Roche Recent Developments; 9.13 H.Lundbeck; 9.13.1 H.Lundbeck Parkinson Disease Drug Basic Information; 9.13.2 H.Lundbeck Parkinson Disease Drug Product Overview; 9.13.3 H.Lundbeck Parkinson Disease Drug Product Market Performance; 9.13.4 H.Lundbeck Business Overview; 9.13.5 H.Lundbeck Recent Developments; 9.14 Valeant; 9.14.1 Valeant Parkinson Disease Drug Basic Information; 9.14.2 Valeant Parkinson Disease Drug Product Overview; 9.14.3 Valeant Parkinson Disease Drug Product Market Performance; 9.14.4 Valeant Business Overview; 9.14.5 Valeant Recent Developments; 9.15 Apokyn; 9.15.1 Apokyn Parkinson Disease Drug Basic Information; 9.15.2 Apokyn Parkinson Disease Drug Product Overview; 9.15.3 Apokyn Parkinson Disease Drug Product Market Performance; 9.15.4 Apokyn Business Overview; 9.15.5 Apokyn Recent Developments; 9.16 Orion; 9.16.1 Orion Parkinson Disease Drug Basic Information; 9.16.2 Orion Parkinson Disease Drug Product Overview; 9.16.3 Orion Parkinson Disease Drug Product Market Performance; 9.16.4 Orion Business Overview; 9.16.5 Orion Recent Developments; 9.17 Stada Arzneimittel; 9.17.1 Stada Arzneimittel Parkinson Disease Drug Basic Information; 9.17.2 Stada Arzneimittel Parkinson Disease Drug Product Overview; 9.17.3 Stada Arzneimittel Parkinson Disease Drug Product Market Performance; 9.17.4 Stada Arzneimittel Business Overview; 9.17.5 Stada Arzneimittel Recent Developments; 9.18 US WorldMeds; 9.18.1 US WorldMeds Parkinson Disease Drug Basic Information; 9.18.2 US WorldMeds Parkinson Disease Drug Product Overview; 9.18.3 US WorldMeds Parkinson Disease Drug Product Market Performance; 9.18.4 US WorldMeds Business Overview; 9.18.5 US WorldMeds Recent Developments; 9.19 Bausch Health; 9.19.1 Bausch Health Parkinson Disease Drug Basic Information; 9.19.2 Bausch Health Parkinson Disease Drug Product Overview; 9.19.3 Bausch Health Parkinson Disease Drug Product Market Performance; 9.19.4 Bausch Health Business Overview; 9.19.5 Bausch Health Recent Developments
10 Parkinson Disease Drug Market Forecast by Region: 10.1 Global Parkinson Disease Drug Market Size Forecast; 10.2 Global Parkinson Disease Drug Market Forecast by Region; 10.2.1 North America Market Size Forecast by Country; 10.2.2 Europe Parkinson Disease Drug Market Size Forecast by Country; 10.2.3 Asia Pacific Parkinson Disease Drug Market Size Forecast by Region; 10.2.4 South America Parkinson Disease Drug Market Size Forecast by Country; 10.2.5 Middle East and Africa Forecasted Consumption of Parkinson Disease Drug by Country
11 Forecast Market by Type and by Application (2024-2029): 11.1 Global Parkinson Disease Drug Market Forecast by Type (2024-2029); 11.1.1 Global Forecasted Sales of Parkinson Disease Drug by Type (2024-2029); 11.1.2 Global Parkinson Disease Drug Market Size Forecast by Type (2024-2029); 11.1.3 Global Forecasted Price of Parkinson Disease Drug by Type (2024-2029); 11.2 Global Parkinson Disease Drug Market Forecast by Application (2024-2029); 11.2.1 Global Parkinson Disease Drug Sales (K MT) Forecast by Application; 11.2.2 Global Parkinson Disease Drug Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings